Syndax Pharmaceuticals, Inc. (SNDX)
USD 13.24
(-2.86%)
USD 13.24
(-2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -160.6 Million | -133.67 Million | 29.13 Million | -71.26 Million | -50.61 Million | -68.53 Million |
| Net Income | -209.36 Million | -149.33 Million | 24.92 Million | -73.15 Million | -56.04 Million | -73.96 Million |
| Depreciation & Amortization | 12 Thousand | 33 Thousand | 43 Thousand | 89 Thousand | 92 Thousand | 78 Thousand |
| Deferred income taxes | -5.61 Million | - | 255 Thousand | -130 Thousand | -780 Thousand | -558 Thousand |
| Stock-based compensation | 30.95 Million | 16.01 Million | 13.31 Million | 9.05 Million | 6 Million | 6.2 Million |
| Change in working capital | 31.86 Million | 1.65 Million | -9.59 Million | -7.93 Million | -241 Thousand | -302 Thousand |
| Other non-cash items | -8.45 Million | -2.04 Million | 187 Thousand | 816 Thousand | 359 Thousand | 11 Thousand |
| Investing Cash Flow | 117.6 Million | -186.18 Million | -40.87 Million | -142.53 Million | 12.78 Million | 51.39 Million |
| Investments in PPE | - | -225 Thousand | -129 Thousand | - | - | -187 Thousand |
| Acquisitions | - | 225 Thousand | 40.74 Thousand | - | - | - |
| Investment purchases | -354.6 Million | -495.34 Million | -294.71 Million | -278.93 Million | -104.01 Million | -78.84 Million |
| Sales/Maturities of investments | 472.21 Million | 308.93 Million | 253.97 Million | 136.4 Million | 116.79 Million | 130.42 Million |
| Other Investing Activities | 117.6 Thousand | 225 Thousand | -40.74 Thousand | -142.53 Thousand | 12.78 Thousand | 51.58 Thousand |
| Financing Cash Flow | 264.13 Million | 172.25 Million | 118.46 Million | 304.42 Million | 28.57 Million | 15.72 Million |
| Debt repayment | - | -20.99 Million | - | -19.73 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 24.84 Million | - | - | - |
| Common Stock Issuance | 258.09 Million | 181.79 Million | 118.46 Million | 284.69 Million | 28.57 Million | 15.49 Million |
| Other Financing Activities | 6.03 Million | 11.45 Million | 118.46 Million | 284.69 Million | 28.57 Million | 232 Thousand |
| Accounts receivables | 10.7 Million | -3.47 Million | - | - | - | - |
| Accounts payables | 5.61 Million | -1.31 Million | 2.16 Million | -2.67 Million | 4.73 Million | -792 Thousand |
| Inventory | -10.7 Million | 3.47 Million | - | - | - | - |
| Other working capital | 26.24 Million | 2.97 Million | -11.75 Million | -5.26 Million | -4.98 Million | 490 Thousand |
| Cash at beginning of period | 74.47 Million | 222.08 Million | 115.35 Million | 24.72 Million | 33.98 Million | 35.38 Million |
| Cash at end of period | 295.61 Million | 74.47 Million | 222.08 Million | 115.35 Million | 24.72 Million | 33.98 Million |
| Capital Expenditure | - | -225 Thousand | -129 Thousand | - | - | -187 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 221.14 Million | -147.6 Million | 106.72 Million | 90.63 Million | -9.26 Million | -1.4 Million |
| Free Cash Flow | -160.6 Million | -133.9 Million | 29 Million | -71.26 Million | -50.61 Million | -68.71 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -84.12 Million | -68.06 Million | -72.4 Million | -209.36 Million | -72.47 Million | -51.14 Million |
| Depreciation & Amortization | 2000.00 | 3000.00 | 3000.00 | 12 Thousand | 3000.00 | 3000.00 |
| Deferred income taxes | - | - | - | -5.61 Million | 7.37 Million | -3.65 Million |
| Stock-based compensation | 11.93 Million | 9.89 Million | 8.89 Million | 30.95 Million | 8.32 Million | 8.32 Million |
| Change in working capital | 26.54 Million | -10.07 Million | -16.47 Million | 31.86 Million | 26.01 Million | 1.59 Million |
| Other non-cash items | -16.67 Million | 11.68 Million | 12.23 Million | -8.45 Million | -10.59 Million | 237 Thousand |
| Investing Cash Flow | 86.84 Million | 61.75 Million | -99.39 Million | 117.6 Million | -16.29 Million | 40.07 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -13.35 Million | - | -167.38 Million | -354.6 Million | -129.29 Million | -82.72 Million |
| Sales/Maturities of investments | 100.2 Million | 61.75 Million | 67.98 Million | 472.21 Million | 113 Million | 122.8 Million |
| Other Investing Activities | - | 61.75 Million | -99.39 Million | 117.6 Thousand | -16.29 Million | 40.07 Million |
| Financing Cash Flow | 3.09 Million | 676 Thousand | 2.16 Million | 264.13 Million | 258.48 Million | 1.85 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -2.84 Million | 676 Thousand | 2.16 Million | 258.09 Million | 258.09 Million | 1.85 Million |
| Other Financing Activities | 5.94 Million | 676 Thousand | 2.16 Million | 6.03 Million | 389 Thousand | 1851.00 |
| Accounts receivables | 13.71 Million | -7.95 Million | -5.75 Million | 10.7 Million | -67.99 Thousand | -3.89 Million |
| Accounts payables | -6.67 Million | 2.75 Million | -1.15 Million | 5.61 Million | 3.91 Million | -4.93 Million |
| Inventory | - | - | - | -10.7 Million | 67.99 Thousand | 3.89 Million |
| Other working capital | 14.44 Million | -4.88 Million | -9.56 Million | 26.24 Million | 22.09 Million | 6.52 Million |
| Cash at beginning of period | 105.39 Million | 114.61 Million | 295.39 Million | 74.47 Million | 94.76 Million | 97.49 Million |
| Cash at end of period | 133.23 Million | 105.39 Million | 114.61 Million | 295.61 Million | 295.61 Million | 94.76 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 27.84 Million | -9.21 Million | -180.77 Million | 221.14 Million | 200.84 Million | -2.72 Million |
| Free Cash Flow | -62.32 Million | -71.64 Million | -83.54 Million | -160.6 Million | -41.34 Million | -44.65 Million |
0QZZ
6058
0FNZ
MYGN
5602
AZASF